Correlation Between Adicet Bio and Cue Biopharma
Can any of the company-specific risk be diversified away by investing in both Adicet Bio and Cue Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Adicet Bio and Cue Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Adicet Bio and Cue Biopharma, you can compare the effects of market volatilities on Adicet Bio and Cue Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Adicet Bio with a short position of Cue Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Adicet Bio and Cue Biopharma.
Diversification Opportunities for Adicet Bio and Cue Biopharma
-0.3 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Adicet and Cue is -0.3. Overlapping area represents the amount of risk that can be diversified away by holding Adicet Bio and Cue Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cue Biopharma and Adicet Bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Adicet Bio are associated (or correlated) with Cue Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cue Biopharma has no effect on the direction of Adicet Bio i.e., Adicet Bio and Cue Biopharma go up and down completely randomly.
Pair Corralation between Adicet Bio and Cue Biopharma
Given the investment horizon of 90 days Adicet Bio is expected to generate 0.72 times more return on investment than Cue Biopharma. However, Adicet Bio is 1.39 times less risky than Cue Biopharma. It trades about 0.01 of its potential returns per unit of risk. Cue Biopharma is currently generating about -0.01 per unit of risk. If you would invest 137.00 in Adicet Bio on September 2, 2024 and sell it today you would lose (24.00) from holding Adicet Bio or give up 17.52% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Adicet Bio vs. Cue Biopharma
Performance |
| Timeline |
| Adicet Bio |
| Cue Biopharma |
Adicet Bio and Cue Biopharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Adicet Bio and Cue Biopharma
The main advantage of trading using opposite Adicet Bio and Cue Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Adicet Bio position performs unexpectedly, Cue Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cue Biopharma will offset losses from the drop in Cue Biopharma's long position.| Adicet Bio vs. Edgewise Therapeutics | Adicet Bio vs. Cullinan Oncology LLC | Adicet Bio vs. Vor Biopharma | Adicet Bio vs. Tenaya Therapeutics |
| Cue Biopharma vs. Coya Therapeutics, Common | Cue Biopharma vs. Lantern Pharma | Cue Biopharma vs. Fennec Pharmaceuticals | Cue Biopharma vs. Eliem Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Other Complementary Tools
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |